| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 9.277 | 59.782 | 48.687 | 59.870 | 35.209 |
| Total Income - EUR | - | - | - | - | - | 9.279 | 59.895 | 48.890 | 60.414 | 36.075 |
| Total Expenses - EUR | - | - | - | - | - | 5.449 | 18.164 | 26.847 | 24.740 | 18.125 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 3.830 | 41.731 | 22.043 | 35.674 | 17.951 |
| Net Profit/Loss - EUR | - | - | - | - | - | 3.737 | 41.197 | 21.690 | 35.161 | 17.627 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Raizin Therapy S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 330 | 1.827 | 2.601 | 2.053 |
| Current Assets | - | - | - | - | - | 5.232 | 41.539 | 21.408 | 35.288 | 18.060 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 81 |
| Receivables | - | - | - | - | - | 1.172 | 28.301 | 20.832 | 644 | 12.323 |
| Cash | - | - | - | - | - | 4.060 | 13.238 | 576 | 34.644 | 5.655 |
| Shareholders Funds | - | - | - | - | - | 3.779 | 41.246 | 22.015 | 36.893 | 19.351 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.421 | 662 | 1.401 | 1.094 | 869 |
| Income in Advance | - | - | - | - | - | 93 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Raizin Therapy S.r.l.